Dr Harshkova focus on the phytotoxicity of pharmaceuticals, particularly diclofenac, using Chlamydomonas reinhardtii as a model organism. Her research demonstrated that diclofenac affects mitochondrial function, disrupts the cell cycle, and induces oxidative stress in algae, which could have profound implications for aquatic ecosystems. PhD degree received on 2024 year. As a principal investigator of the PRELUDIUM grant (NCN) (2021-2024), she examined the mitochondrial toxicity of NSAIDs at the cellular level. Additionally, as a co-investigator in two OPUS grants (NCN) (2017-2024), she investigated the sensitivity and remediation potential of planktonic green algae exposed to pharmaceutical pollutants. Her six-month research stay at ALGATECH – The Centre of Algal Biotechnology in Třeboň, Czech Republic (2020-2021), supported by the Wilhelmina Iwanowska Scholarship (NAWA), allowed her to refine her methodologies in algal physiology and expand international collaborations. Currently Darya Harshkova works as a assistant at the Department of Plant Experimental Biology and Biotechnology and she is the author and co-author of over 30 scientific publications and conference reports.